참고문헌
-
Loveless, A. & Hampton, C.L. Inactivation and mutation of coliphage
$T_{2}$ by N-methyl-N- and N-ethyl-Nnitrosourea. Mutation Res. 7, 1-12(1969) https://doi.org/10.1016/0027-5107(69)90043-8 - Magee, P.N. & Barnes, J.M. Carcinogenic nitroso compounds. Adv. Cancer Res. 10, 164-246 (1967)
- Russel, W.L. et al. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl. Acad. Sci. USA. 76, 5818-5819 (1979) https://doi.org/10.1073/pnas.76.11.5818
- Murota, T. & Shibuya, T. Genetics analysis of mutants in mice induced by N-ethyl-N-nitrosourea. Jpn. J. Genet. 58, 263-267 (1983) https://doi.org/10.1266/jjg.58.263
- Magee, P.N. & Barnes, J.M. Carcinogenic nitroso compounds. Adv. Cancer Res. 10, 164-246 (1967)
- Pennie, W.D., Tugwood, J.D., Oliver, G.J.A. & Kimber, I. The principles and practice of toxicogenomics: Applications and opportunities. Toxicol. Sci. 54, 277-283 (2000) https://doi.org/10.1093/toxsci/54.2.277
- Ulrich, R. & Friend, S.H. Toxicogenomics and drug discovery: Will new technologies help us produce better drugs? Nature Reviews, 1, 84-88 (2002) https://doi.org/10.1038/nrd710
- Bertucci, F. et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum. Mol. Genet. 9, 2981-2991 (2000) https://doi.org/10.1093/hmg/9.20.2981
- Devilard, E. et al. Gene expression profiling defines molecular subtypes of classical Hodgkin's disease. Oncogene 21, 3095-3102 (2002) https://doi.org/10.1038/sj.onc.1205418
- Mitsiades, N. et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. U.S.A. 99, 14374-14379 (2002) https://doi.org/10.1073/pnas.202445099
- Baumann, G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr. Rev. 12, 424-449 (1991) https://doi.org/10.1210/edrv-12-4-424
- Costoya, J.A. et al. Expression of the human growth hormone normal gene (hGH-N) in proliferating and differentiated HL-60 cells. Exp. Cell. Res. 228, 164- 167 (1996) https://doi.org/10.1006/excr.1996.0312
- Fraser, R.A., Attardo, D. & Harvey, S. Growth hormone receptors in hypothalamic and extra hypothalamic tissues. J. Mol. Endocrinol. 5, 231-238 (1990) https://doi.org/10.1677/jme.0.0050231
- Levine, A.J. p53, the cellular gatekeeper for growth and division, Cell 88, 323-331 (1997) https://doi.org/10.1016/S0092-8674(00)81871-1
- Vousden, K.H. & Lu, X. Live or let die: the cell's response to p53, Nat. Rev. Cancer 2, 594-604 (2002) https://doi.org/10.1038/nrc864
- Mitsumori, K. et al. Rapid induction of uterine tumors with p53 point mutation in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea, Carcinogenesis 21(5), 1039-1042(2000) https://doi.org/10.1093/carcin/21.5.1039
- Kagi, J.H.R. Overview of metallothionein. Metallobiochemistry Part B: metallothionein and related molecules. Methods Enzymol. 205, 613-626 (1993)
- Silvestro, D. & Carlson, G.P. Inflammation an inducer of metallothionein inhibits carbon tetrachlorideinduced hepatotoxicity in rats. Toxicol. lett. 60, 175- 181 (1992) https://doi.org/10.1016/0378-4274(92)90272-L
- Cherian, M.G. et al. National cancer institute workshop on possible roles of metallothionein in carcinogenesis. Cancer Res. 53, 922-925 (1993)
- Kelly, S.L. et al. Over expression of metallothionein confers resistance to anti-cancer drugs. Science 241, 1813-1815 (1988) https://doi.org/10.1126/science.3175622
- Joseph, M.G. et al. Metallothionein expression in patients with small cell carcinoma of the lung. Correlation with other molecular markers and clinical out come. Cancer 92, 836-842(2001) https://doi.org/10.1002/1097-0142(20010815)92:4<836::AID-CNCR1390>3.0.CO;2-K